Item 7.01. Regulation FD Disclosure.

On January 12, 2022, NuVasive, Inc. (the "Company") made available to investors a presentation (the "Investor Presentation") that includes updates on Company business trends, performance, and opportunities for future growth and value creation. The Company plans to present information contained in the Investor Presentation to analysts and investors from time to time, including at upcoming investor conferences. A copy of the Investor Presentation is available on the Investor Relations section of the Company's website at www.nuvasive.com and is being furnished as Exhibit 99.1 hereto.

The information contained in this Current Report and the Exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.





Item 9.01.    Financial Statements and Exhibits.

(d)           Exhibits.

Exhibit No.   Description
99.1            Investor Presentation dated January 12, 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses